Programme

Vertical Tabs

Programme schedule

Please find below the schedule of the scientific programme of the 21st EAHP congress.

Click here for the PDF version of the programme.

EAHP confirms that the Speakers and the Scientific Committee members responsible for the development of the Congress programme have signed and submitted the Conflict of Interest Disclosure forms.

* Indicates speaker or SC member has stated a conflict of interest.

The European Association of Hospital Pharmacists (EAHP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 

Tuesday, 15 March
12.00 - 17.00  Group and exhibitor registrations  Entrance Hall
 
Wednesday, 16 March
Date/Time Meetings/Events Room
07.00 - 17.00 Registration opens (individual, groups and exhibitors) Entrance Hall
09.20 - 11.15

Opening ceremony & Keynote 1 - Patient partnership in healthcare, a necessary transition?

ACPE UAN: 0475-0000-16-001-L04-P. A knowledge based activity.

V. Dumez; M.-C. Vanier

Hall A
11.15 Exhibition opens Hall X2
11.30 - 13.00 Synergy Satellite  
 

Interchangeability of biologicals in the EU – the science, practice, ethics and cost side? (supported by an educational grant from Roche)

ACPE UAN: 0475-0000-16-004-L04-P. A knowledge based activity.

D.J.A. CrommelinP. Declerck*; A.G. Vulto*; P. Cornes*

Hall D
13.00 - 13.30

Bayer - Meet the Expert

"Potential Role of Pharmacists in AF Screening, Diagnosis and NOACs Treatment and the Impact of New Technology"

S. Antoniou, B. Freedman 

Hall X2

Stand 50

13.30 - 14.00

Bayer - Meet the Expert

"NOACs in the Hospital and Interprofessional Communication"

J. Muen; R. Hughes

Hall X2

Stand 50

13.00 - 14.00 Lunch Hall X2
14.00 - 18.00

Student Programme - A systematic approach to pharmaceutical care – what is this all about and how can it be implemented by the hospital pharmacist?

ACPE UAN: 0475-0000-16-027-L04-P. A knowledge based activity.

A. Tonna; S. Cunningham; R. Edwards

Hall L3
14.00 - 15.30 Seminars

Seminar P1 - Redesigning services around the patient

ACPE UAN: 0475-0000-16-006-L04-P. A knowledge based activity.

J. Aston; M. McLoughlin

Hall E1

Seminar P2 - New and emerging roles for pharmacy staff

ACPE UAN: 0475-0000-16-007-L04-P. A knowledge based activity.

M. Scott*; M. Slimm

Hall E2

Seminar PH3 - Developing new strategies in bacterial infections

ACPE UAN: 0475-0000-16-018-L04-P. A knowledge based activity.

A. Huttner; M. G. Voßen

Hall F1

Seminar T2 - Empowering patients through technology - "The Quantified Self" 

ACPE UAN: 0475-0000-16-012-L04-P. A knowledge based activity.

C. Vorilhon; J. Söderberg

Hall F2

Seminar PH1 - "Wonder pills", breakthroughs and continuing challenges - HIV and Hepatitis C antiviral treatments revisited

ACPE UAN:0475-0000-16-016-L04-P. A knowledge based activity.

V. Pourcher-Martinez*; H. Hofer

Hall G

Interactive Session 1 - Hospital Pharmacists taking the lead in Orphan Drugs: supply chain, partnerships and technologies

ACPE UAN: 0475-0000-16-021-L04-P. An application based activity.

M. Dooms

Hall 1.61&1.62

Workshop 3 - Patient empowerment & communication

ACPE UAN: 0475-0000-16-026-L04-P. An application based activity.

S. TessierM.-C. Vanier

Hall -2.31

Poster nominee oral presentations

MEDICINE SUPPLY CHAIN OF A CENTRAL PHARMACY : RISK MAPPING OF SHORTAGE - Charra, Florent;

CONTAMINATION WITH CYTOTOXIC DRUGS IN THE WORKPLACE - ESOP PILOT STUDY - Korczowska, Ewelina; 

DOUBLE CHECKING MANIPULATIONS FOR COMPLEX AND/OR HIGH RISK PREPARATIONS - Alcobia Martins, Armando;

THE CLINICAL PHARMACIST RESOLVES MEDICATION RELATED PROBLEMS IN CRANIO, MAXILLOFACIAL AND ORAL SURGERY PATIENTS - Tudela-Lopez, Emilie;

THE IMPACT OF PHARMACIST INTERVENTIONS ON SAFETY AND COST SAVINGS - Tovar Pozo, Maria; 

EFFECTIVENESS AND SAFETY OF SWITCHING TO DUAL ANTIRETROVIRAL THERAPY IN A TREATMENT EXPERIENCED HIV COHORT - Revuelta, Jose Luis;

IMPLEMENTATION AND EVALUATION OF AN APPOINTMENT BASED MODEL FOR OUTPATIENTS ATTENDED IN A HOSPITAL PHARMACY - Alvarez Mancenido, Felipe;

CLINICAL PHARMACOKINETICS OF EVEROLIMUS IN LUNG TRANSPLANTATION: STRATEGIES OF MONITORING - Martín Cerezuela, Maria.

Hall 0.93
Industry sponsored satellites
Pfizer Hall K
AbbVie Inc. Hall M
15.30 - 16.15 Coffee break Hall X2
16.15 - 17.45 Seminars

Seminar T5 - Novel ways of dispensing drugs

ACPE UAN: 0475-0000-16-015-L04-P. A knowledge based activity.

N. MoermanA. Vermes

Hall E1

Seminar P4 - Sharing pharmacy information for safer transition of care

ACPE UAN: 0475-0000-16-009-L04-P. A knowledge based activity.

F. Karapinar-ÇarkitR. Santolaya Perrin

Hall E2

Seminar T3 - E-learning: application and implementation

ACPE UAN: 0475-0000-16-013-L04-P. A knowledge based activity.

S. Renet*; A. Bygholm

Hall F1

Seminar PH2 - Cancer Therapy: review of the present and a look to the future

ACPE UAN: 0475-0000-16-017-L04-P. A knowledge based activity.

A. R. Rubio SalvadorJ. Gullbo

Hall F2

Seminar T1 - The hospital pharmacist and the e-health revolution

ACPE UAN: 0475-0000-16-011-L04-P. A knowledge based activity.

J. Vanhoof; T. Eriksson*; J. Surugue

Hall G

Workshop 2 - The art of writing an abstract

ACPE UAN: 0475-0000-16-025-L04-P. An application based activity.

G. Stemer; T. Hoppe-Tichy

Hall -2.31

Industry sponsored satellite and workshop

  Hall K

 Sun Pharma Hall M

Bayer workshop

Hall 1.61&1.62
17.45 - 19.30 Get together reception  Hall X2
19.30 - 21.00 Poster walk Main Entrance Hall



Thursday, 17 March
Date/Time Meetings/Events Room
08.00 - 17.00 Registration opens (individual, groups and exhibitors) Entrance Hall
09.00 - 10.30 Seminars

Seminar P5 - Advances in clinical services: medicines optimisation 

ACPE UAN: 0475-0000-16-010-L04-P. A knowledge based activity.

B. Hennie GarciaA. Alassaad

Hall E1

Seminar T4 - Are clinical decision support systems beneficial for everyone?

ACPE UAN: 0475-0000-16-014-L04-P. A knowledge based activity.

B. L. HugA.M. Scheepers-Hoeks

Hall E2

Seminar P3 - Clinical pathways concept - a key to seamless care

ACPE UAN: 0475-0000-16-008-L04-P. A knowledge based activity.

M.-C. Chaumais*; A. Janoly-Dumenil

Hall F1

Seminar PH4 - Advanced-therapy medicinal products: new competencies in hospital pharmacy

ACPE UAN: 0475-0000-16-019-L04-P. A knowledge based activity.

A. Black

Hall F2

Seminar PH5 - Individualised therapy - managing the differences

ACPE UAN: 0475-0000-16-020-L04-P. A knowledge based activity.

U. JaehdeD. Touw

Hall G

Workshop 1 - Antimicrobial optimisation: an interactive workshop for hospital pharmacists

ACPE UAN: 0475-0000-16-024-L04-P. An application based activity.

A. Tonna; J. Sneddon

Hall -2.31

Interactive Session 2 - Implementing new technology: key factors to success

ACPE UAN: 0475-0000-16-022-L04-P. An application based activity.

C. Hedegård LagerC. Brincker ThiesenT. Klok Wrønding

Hall N

Interactive Session 3 - Developing and implementing clinical pathways

ACPE UAN: 0475-0000-16-023-L04-P. An application based activity.

V. Fortineau

Hall 1.61&1.62

Poster nominee oral presentations

DOES THE COMPUTERIZED PHYSICIAN ORDER ENTRY SYSTEM REDUCE PRESCRIBING ERRORS FOR INPATIENTS ? A BEFORE-AFTER STUDY - Rouayroux, Naïs;

APPS FOR PAEDIATRIC DOSING - AN EVALUATION - Vonbach, Priska;

IMPROVING PHARMACOLOGICAL TREATMENT: REAL-TIME SAFETY AUDITS - López Broseta, Pilar Ana;

MATERIOVIGILANCE EX ANTE RISK MANAGEMENT - Dubromel, Amelie;

HEALTH-RELATED QUALITY OF LIFE AND ITS ASSOCIATED FACTORS AMONG SOUTH ASIAN AND MIDDLE EASTERN PATIENTS WITH CHRONIC DISEASES IN THE UK - Alhomoud, Faten;

INNAPPROPRIATE PRESCRIBING IN ELDERLY PATIENTS ATTENDING THE EMERGENCY ROOM - Sánchez Navarro, Isabel;

PROSPECTIVE DETECTION OF ADVERSE DRUG REACTIONS AMONG 2,263 HOSPITALIZED CHILDREN OVER A 19-MONTH PERIOD - EREMI INTERMEDIATE REPORT - Lajoinie, Audrey.

Hall 0.93

Industry sponsored satellites and interactive sessions

Merck Sharp & Dohme Corp.    Hall M

Fresenius Kabi Hall K
  AMGEN Europe GmbH: Interactive Session Hall L3

Teva Pharmeceuticals Europe BV: Interactive Session Hall 0.49&0.50
10.30 - 11.00

Bayer - Meet The Expert

"NOACs in the Hospital – The Role of Pharmacists in Optimal Medication Use and Adherence"

C. Coleman

Hall X2

Stand 50

10.30 - 11.00 Coffee break and attended posters Hall X2 and Main Entrance Foyer
11.00 - 12.00

Keynote 2 - Star Trek's tricorder: science fiction or future science?

ACPE UAN: 0475-0000-16-002-L04-P. A knowledge based activity.

K. Wac

Hall D
  Synergy interactive session  
 

Ready to use Drugs - a useful option for patient safety (supported by an educational grant from Roche)

ACPE UAN: 0475-0000-16-005-L04-P. An application based activity.

P. Le BrunA.M. Beaney

 Hall 0.49&0.50
12.00 - 13.30 Seminars

Seminar P1 - Redesigning services around the patient

ACPE UAN: 0475-0000-16-006-L04-P. A knowledge based activity.

J. Aston; M. McLoughlin

Hall E1

Seminar P2 - New and emerging roles for pharmacy staff

ACPE UAN: 0475-0000-16-007-L04-P. A knowledge based activity.

M. Scott*; M. Slimm

Hall E2

Seminar PH3 - Developing new strategies in bacterial infections

ACPE UAN:0475-0000-16-018-L04-P. A knowledge based activity.

A. Huttner; M. G. Voßen

Hall F1

Seminar T2 - Empowering patients through technology - "The Quantified Self"

ACPE UAN: 0475-0000-16-012-L04-P. A knowledge based activity.

C. VorilhonJ. Söderberg

Hall F2

Seminar PH1 - "Wonder pills", breakthroughs and continuing challenges - HIV and Hepatitis C antiviral treatments revisited

ACPE UAN:0475-0000-16-016-L04-P. A knowledge based activity.

V. Pourcher-Martinez*; H. Hofer

Hall G

Interactive Session 1 - Hospital Pharmacists taking the lead in Orphan Drugs: supply chain, partnerships and technologies

ACPE UAN: 0475-0000-16-021-L04-P. An application based activity.

M. Dooms

Hall 1.61&1.62

Workshop 3 - Patient empowerment & communication

ACPE UAN: 0475-0000-16-026-L04-P. An application based activity.

S. TessierM.-C. Vanier

Hall -2.31

Good Practice Initiative oral presentations

RENAL PHARMACIST OPTIMISES HEALTH OUTCOMES FOR PATIENTS - Frisch, A.

DEVELOPMENT OF A 7-DAY CLINICAL PHARMACY SERVICE - Antoniou, S.

IS IT POSSIBLE TO TURN AROUND THE TREND ON THE INCREASING AMOUNT OF BACKORDERS - ON NATIONAL LEVEL - Munck, L.

DEVELOPMENT OF A COMPUTER APPLICATION TO REDUCE THE RISK OF ERRORS IN RECONSTITUTION OF CYTOTOXIC DRUGS - Cheikh, A.

DEVELOPMENT OF AN INTERACTIVE PLATFORM FOR PROVINCE CLINICAL PHARMACEUTICS WHO ARE IN CHARGE OF THE TREATMENT OF HEPATITIS C INFECTED PATIENTS -  Martín Marqués, M.

IMMPACT: A THERAPEUTIC EDUCATION PROGRAM TO SUPPORT SEAMLESS CARE FOR PATIENTS LIVING WITH CANCER - Decottignies, A.

INFLUENCE OF INTEGRATION OF A PHARMACIST IN MEDICATION ERRORS IN CRITICALLY ILL PATIENTS - Domingo-Chiva, E.

EASE OF ACCESS TO INTRAVENOUS DRUG COMPATIBILITY INFORMATION FOR CLINICAL PRACTITIONERS - Teimori, K.

INTRODUCTION OF A PATIENT-CENTRED CLINICAL PHARMACY TRAINING SCHEME IN A LARGE UNIVERSITY HOSPITAL PHARMACY - Past, E.

SYSTEMATIC APPROACH FOR TRAINING HOSPITAL PHARMACISTS TO PRACTICE CLINICAL MEDICATION MANAGEMENT - Walk-Fritz, S.

Hall 0.93

Industry sponsored satellites and workshop

Boehringer-Ingelheim Hall K
Teva Pharmaceuticals Europe BV Hall M

Bayer workshop

Hall N
13.30 - 15.00 Lunch Hall X2
15.00 - 16.30 Seminars

Seminar T5 - Novel ways of dispensing drugs

ACPE UAN: 0475-0000-16-015-L04-P. A knowledge based activity.

N. MoermanA. Vermes

Hall E1

Seminar P4 - Sharing pharmacy information for safer transition of care

ACPE UAN: 0475-0000-16-009-L04-P. A knowledge based activity.

F. Karapinar-ÇarkitR. Santolaya Perrin

Hall E2

Seminar T3 - E-learning: application and implementation

ACPE UAN: 0475-0000-16-013-L04-P. A knowledge based activity.

S. Renet*; A. Bygholm

Hall F1

Seminar PH2 - Cancer Therapy: review of the present and a look to the future

ACPE UAN: 0475-0000-16-017-L04-P. A knowledge based activity.

A. R. Rubio SalvadorJ. Gullbo 

Hall F2

Seminar T1 - The hospital pharmacist and the e-health revolution

ACPE UAN: 0475-0000-16-011-L04-P. A knowledge based activity.

 J. VanhoofT. Eriksson*; J. Surugue

Hall G

Workshop 2 - The art of writing an abstract

ACPE UAN: 0475-0000-16-025-L04-P. An application based activity.

G. Stemer; T. Hoppe-Tichy

Hall -2.31
Industry sponsored satellites and interactive session
European Biosimilars Group (EBG) Hall K

Pfizer  Hall M

Merck Sharp & Dohme Corp.

Hall D


AMGEN Europe GmbH: Interactive Session Hall L3
16.30 - 17.00

Bayer - Meet the Expert

"Potential Role of Pharmacists in AF Screening, Diagnosis and NOACs Treatment and the Impact of New Technology"

S. Antoniou; B. Freedman 

Hall X2

Stand 50

16.30 - 17.00 Coffee break Hall X2



Friday, 18 March
Date/Time Meetings/Events Room
08.00 - 11.00 Registration opens (individual, groups and exhibitors) Entrance Hall
  Synergy Interactive Session  
 

Ready to use Drugs - a useful option for patient safety (supported by an educational grant from Roche)

ACPE UAN: 0475-0000-16-005-L04-P. An application based activity.

P. Le BrunA.M. Beaney

 Hall 0.49&0.50
09.00 - 10.30 Seminars

Seminar P5 - Advances in clinical services: medicines optimisation

ACPE UAN: 0475-0000-16-010-L04-P. A knowledge based activity.

B. Hennie GarciaA. Alassaad

Hall E1

Seminar T4 - Are clinical decision support systems beneficial for everyone?

ACPE UAN: 0475-0000-16-014-L04-P. A knowledge based activity.

B. L. HugA. M. Scheepers-Hoeks

Hall E2

Seminar P3 - Clinical pathways concept - a key to seamless care

ACPE UAN: 0475-0000-16-008-L04-P. A knowledge based activity.

M.-C. Chaumais*; A. Janoly-Dumenil

Hall F1

Seminar PH4 - Advanced-therapy medicinal products: new competencies in hospital pharmacy

ACPE UAN: 0475-0000-16-019-L04-P. A knowledge based activity.

A. Black

Hall F2

Seminar PH5 - Individualised therapy - managing the differences

ACPE UAN: 0475-0000-16-020-L04-P. A knowledge based activity.

U. JaehdeD. Touw 

Hall G

Workshop 1 - Antimicrobial optimisation: an interactive workshop for hospital pharmacists

ACPE UAN: 0475-0000-16-024-L04-P. An application based activity.

A. Tonna; J. Sneddon

Hall -2.31

Interactive Session 2 - Implementing new technology: key factors to success

ACPE UAN: 0475-0000-16-022-L04-P. An application based activity.

C. Hedegård LagerC. Brincker ThiesenT. Klok Wrønding

Hall N

Interactive Session 3 - Developing and implementing clinical pathways

ACPE UAN: 0475-0000-16-023-L04-P. An application based activity.

V. Fortineau

Hall 1.61&1.62
10.30 - 11.30 Coffee break and attended posters Hall X2 and Main Entrance Foyer
11.30 - 13.00

Closing ceremony & Keynote 3 - Exploring the future of pharmacotherapy

ACPE UAN: 0475-0000-16-003-L04-P. A knowledge based activity.

H. G. M. Leufkens

Hall D
12.00 Exhibition closes Hall X2
Teaching Goals and Learning Objectives

Date: 

Thursday, 17 March 2016 - 12:00pm to 1:30pm
Friday, 18 March 2016 - 9:00am to 10:30am

Room: 

Hall 0.49&0.50

Facilitator: 

Valladolid Walsh, Ana

Presenter: 

Date: 

Wednesday, 16 March 2016 - 9:30am to 11:15am

Room: 

Hall A

Facilitator: 

Neef, Kees

Presenter: 

Date: 

Thursday, 17 March 2016 - 11:00am to 12:00pm

Room: 

Hall D

Facilitator: 

Neef, Kees

Presenter: 

Date: 

Friday, 18 March 2016 - 11:30am to 1:00pm

Room: 

Hall D

Facilitator: 

Neef, Kees

Presenter: 

Date: 

Wednesday, 16 March 2016 - 2:00pm to 3:30pm
Thursday, 17 March 2016 - 12:00pm to 1:30pm

Room: 

Hall E1

Facilitator: 

Sinclair, Anthony

Presenter: 

Date: 

Wednesday, 16 March 2016 - 2:00pm to 3:30pm
Thursday, 17 March 2016 - 12:00pm to 1:30pm

Room: 

Hall E2

Facilitator: 

Horoszko, Beata

Presenter: 

Date: 

Thursday, 17 March 2016 - 9:00am to 10:30am
Friday, 18 March 2016 - 9:00am to 10:30am

Room: 

Hall F1

Facilitator: 

Sinclair, Anthony

Presenter: 

Date: 

Wednesday, 16 March 2016 - 4:15pm to 5:45pm
Thursday, 17 March 2016 - 3:00pm to 4:30pm

Room: 

Hall E2

Facilitator: 

Valladolid Walsh, Ana

Presenter: 

Date: 

Thursday, 17 March 2016 - 9:00am to 10:30am
Friday, 18 March 2016 - 9:00am to 10:30am

Room: 

Hall E1

Facilitator: 

Gillespie, Ulrika

Presenter: 

Date: 

Wednesday, 16 March 2016 - 4:15pm to 5:45pm
Thursday, 17 March 2016 - 3:00pm to 4:30pm

Room: 

Hall G

Facilitator: 

Chrapkova, Kornelia

Presenter: 

Date: 

Wednesday, 16 March 2016 - 2:00pm to 3:30pm
Thursday, 17 March 2016 - 12:00pm to 1:30pm

Room: 

Hall F2

Facilitator: 

WED: Gouveia, Antonio; THUR: Sviestina, Inese

Presenter: 

Date: 

Wednesday, 16 March 2016 - 4:15pm to 5:45pm
Thursday, 17 March 2016 - 3:00pm to 4:30pm

Room: 

Hall F1

Facilitator: 

Kart, Trine

Presenter: 

Date: 

Thursday, 17 March 2016 - 9:00am to 10:30am
Friday, 18 March 2016 - 9:00am to 10:30am

Room: 

Hall E2

Facilitator: 

THUR: Chrapkova, Kornelia; FRI: Jenzer, Helena

Presenter: 

Date: 

Wednesday, 16 March 2016 - 4:15pm to 5:45pm
Thursday, 17 March 2016 - 3:00pm to 4:30pm

Room: 

Hall E1

Facilitator: 

De Rijdt, Thomas

Presenter: 

Date: 

Wednesday, 16 March 2016 - 2:00pm to 3:30pm
Thursday, 17 March 2016 - 12:00pm to 1:30pm

Room: 

Hall G

Facilitator: 

Stemer, Gunar

Presenter: 

Date: 

Wednesday, 16 March 2016 - 4:15pm to 5:45pm
Thursday, 17 March 2016 - 3:00pm to 4:30pm

Room: 

Hall F2

Facilitator: 

Gouveia, Antonio

Presenter: 

Date: 

Wednesday, 16 March 2016 - 2:00pm to 3:30pm
Thursday, 17 March 2016 - 12:00pm to 1:30pm

Room: 

Hall F1

Facilitator: 

Hoppe-Tichy, Torsten*

Presenter: 

Date: 

Thursday, 17 March 2016 - 9:00am to 10:30am
Friday, 18 March 2016 - 9:00am to 10:30am

Room: 

Hall F2

Facilitator: 

Venturini, Francesca

Presenter: 

Date: 

Thursday, 17 March 2016 - 9:00am to 10:30am
Friday, 18 March 2016 - 9:00am to 10:30am

Room: 

Hall G

Facilitator: 

Miljkovic, Branislava

Presenter: 

Date: 

Wednesday, 16 March 2016 - 2:00pm to 3:30pm
Thursday, 17 March 2016 - 12:00pm to 1:30pm

Room: 

Hall 1.61&1.62

Facilitator: 

WED: De Rijdt, Thomas; THUR: Jenzer, Helena

Presenter: 

Date: 

Thursday, 17 March 2016 - 9:00am to 10:30am
Friday, 18 March 2016 - 9:00am to 10:30am

Room: 

Hall N

Date: 

Thursday, 17 March 2016 - 9:00am to 10:30am
Friday, 18 March 2016 - 9:00am to 10:30am

Room: 

Hall 1.61&1.62

Facilitator: 

Rieutord, André

Presenter: 

Date: 

Thursday, 17 March 2016 - 9:00am to 10:30am
Friday, 18 March 2016 - 9:00am to 10:30am

Room: 

Hall -2.31

Facilitator: 

Hoppe-Tichy, Torsten*

Presenter: 

Date: 

Wednesday, 16 March 2016 - 4:15pm to 5:45pm
Thursday, 17 March 2016 - 3:00pm to 4:30pm

Room: 

Hall -2.31

Facilitator: 

Stemer, Gunar

Presenter: 

Date: 

Wednesday, 16 March 2016 - 2:00pm to 3:30pm
Thursday, 17 March 2016 - 12:00pm to 1:30pm

Room: 

Hall -2.31

Facilitator: 

Rieutord, André

Presenter: 

Speakers
Picture Speaker

 

Seminar P5 - Clinical services with benefits: medicines optimisation

Affiliation:
Health Navigator AB
Country:
Sweden

 

Seminar P1 - Redesigning services around the patient

Affiliation:
Birmingham Children’s Hospital NHS Foundation Trust
Country:
United Kingdom

 

Synergy Interactive Session: Ready to use Drugs - a useful option for patient safety (supported by an educational grant from Roche)

Affiliation:
North East England, NHS
Country:
United Kingdom

 

Speaker for the Opening Ceremony: European Medicines Agency (EMA)

Affiliation:
European Medicines Agency
Country:
United Kingdom

 

Seminar PH4 - Advanced therapy medicinal products - new competencies in hospital pharmacy

Affiliation:
United Kingdom
Country:
The Newcastle upon Tyne Hospitals NHS Trust

 

Interactive Session 2 - Implementing new technology: key factors to success

Affiliation:
Capital Region Pharmacy /Amgros
Country:
Denmark

 

Seminar T3 - E-learning: where to use and how to implement

Affiliation:
Aalborg University
Country:
Denmark

 

Seminar P3 - Clinical pathways concept - a key to seamless care

Affiliation:
Hôpital Antoine Béclère - AP-HP
Country:
France

 

Synergy Satellite: Interchangeability of biologicals in the EU – the science, practice, ethics and cost side? (supported by an educational grant from Roche)

Affiliation:
Comparatve Outcomes Group
Country:
United Kingdom

 

Synergy Satellite: Interchangeability of biologicals in the EU – the science, practice, ethics and cost side? (supported by an educational grant from Roche)

Affiliation:
Utrecht University
Country:
The Netherlands

 

Student Programme: A systematic approach to pharmaceutical care – what is this all about and how can it be implemented by the hospital pharmacist?

Affiliation:
Robert Gordon University
Country:
United Kingdom

 

Synergy Satellite: Interchangeability of biologicals in the EU – the science, practice, ethics and cost side? (supported by an educational grant from Roche)

Affiliation:
University of Leuven
Country:
Belgium

 

Interactive Session 1 - Hospital Pharmacists taking the lead in Orphan Drugs: supply chain, partnerships and technologies

Affiliation:
University Hospitals Leuven
Country:
Belgium

 

Keynote 1 - Patient partnership in healthcare, a necessary transition?

Affiliation:
University of Montreal
Country:
Canada

 

Student Programme: A systematic approach to pharmaceutical care – what is this all about and how can it be implemented by the hospital pharmacist?

Affiliation:
Robert Gordon University
Country:
United Kingdom

 

Seminar T1 - The hospital pharmacist and the e-health revolution

Affiliation:
T.A.K.E.
Country:
Denmark


Interactive Session 3 - Developing and implementing clinical pathways

Affiliation:
KHTEMA
Country:
France

 

Seminar PH2 - Cancer Therapy: review of the present and a look to the future

Affiliation:
Uppsala University Hospital
Country:
Sweden

 

Interactive Session 2 - Implementing new technology: key factors to success

Affiliation:
Region Hovedstaden Apotek
Country:
Denmark

 

Seminar P5 - Clinical services with benefits: medicines optimisation

Affiliation:
University of Tromsø
Country:
Norway

 

Seminar PH1 - "Wonder pills", breakthroughs and continuing challenges – HIV and Hepatitis C antiviral treatments revisited

Affiliation:
Medical University of Vienna
Country:
Austria

 

Workshop 2 - The art of writing an abstract

Affiliation:
University Hospital of Heidelberg
Country:
Germany

 

Seminar T4 - Are clinical decision support systems beneficial for everyone?

Affiliation:
Basel University Hospital
Country:
Switzerland

 

Seminar PH3 - Developing new strategies in bacterial infections

Affiliation:
Geneva University Hospitals
Country:
Switzerland

 

Seminar PH5 - Individualised therapy - managing the differences

Affiliation:
University of Bonn
Country:
Germany

 

Seminar P3 - Clinical pathways concept - a key to seamless care

Affiliation:
Edouard Herriot Hospital - Hospices Civils de Lyon
Country:
France

 

Seminar P4 - Sharing pharmacy information for safer transition of care

Affiliation:
Onze Lieve Vrouwe Gasthuis
Country:
The Netherlands

 

Interactive Session 2 - Implementing new technology: key factors to success

Affiliation:
Alfanordic/Capital Region Pharmacy
Country:
Denmark

 

Synergy Interactive Session: Ready to use Drugs - a useful option for patient safety (supported by an educational grant from Roche)

Affiliation:
Central Hospital Pharmacy of The Hague
Country:
The Netherlands

 

Keynote 3 - Exploring the future of pharmacotherapy

Affiliation:
Dutch Medicines Evaluation Board
Country:
The Netherlands

 

Seminar P1 - Redesigning services around the patient

Affiliation:
Birmingham Children’s Hospital NHS Foundation Trust
Country:
United Kingdom

 

Seminar T5 - Novel ways of dispensing drugs

Affiliation:
University Hospital Leuven
Country:
Belgium


Dignitary speaker for the Opening Ceremony: Minister of Health of Austria

Affiliation:
Austrian Ministry of Health
Country:
Austria

 

Seminar PH1 - "Wonder pills", breakthroughs and continuing challenges – HIV and Hepatitis C antiviral treatments revisited

Affiliation:
Pitié-Salpêtrière Hospital
Country:
France

 

Seminar T3 - E-learning: where to use and how to implement

Affiliation:
Hôpital Antoine Béclère – HUPS – AP-HP
Country:
France

 

Seminar PH2 - Cancer Therapy: review of the present and a look to the future

Affiliation:
Complejo Hospitalario de Toledo
Country:
Spain

 

Seminar P4 - Sharing pharmacy information for safer transition of care

Affiliation:
Hospital Universitario Príncipe de Asturias
Country:
Spain

 

Seminar T4 - Are clinical decision support systems beneficial for everyone?

Affiliation:
Maastricht University Medical Centre
Country:
The Netherlands

 

Seminar P2 - New and emerging roles for pharmacy staff

Affiliation:
Northern Health & Social Care Trust
Country:
United Kingdom

 

Seminar P2 - New and emerging roles for pharmacy staff

Affiliation:
Birmingham Children’s Hospital NHS Foundation Trust
Country:
United Kingdom

 

Workshop 1 - Antimicrobial optimisation: an interactive workshop for hospital pharmacists

Affiliation:
Scottish Antimicrobial Prescribing Group
Country:
United Kingdom

 

Seminar T2 - Empowering patients through technology – "The Quantified Self"

Affiliation:
Health Solutions
Country:
Sweden

 

Workshop 2 - The art of writing an abstract

Affiliation:
Vienna General Hospital – Medical University Campus
Country:
Austria

 

Seminar T1 - The hospital pharmacist and the e-health revolution

Affiliation:
Centre Hospitalier Georges Renon
Country:
France

Workshop 3 - Patient empowerment & communication

Affiliation:
University of Nanterre Paris Ouest
Country:
France

 

Workshop 1 - Antimicrobial optimisation: an interactive workshop for hospital pharmacists

Student Programme: A systematic approach to pharmaceutical care – what is this all about and how can it be implemented by the hospital pharmacist?

Affiliation:
Robert Gordon University, Aberdeen
Country:
United Kingdom

 

Seminar PH5 - Individualised therapy - managing the differences

Affiliation:
University Medical Center and University Groningen
Country:
The Netherlands

 

Seminar T1 - The hospital pharmacist and the e-health revolution

Affiliation:
University of Leuven
Country:
Belgium

 

Keynote 1 - Patient partnership in healthcare, a necessary transition?

Affiliation:
Université de Montréal, Quebec, Canada and Centre intégré de santé et services sociaux (CISSS) de Laval
Country:
Canada

 

Seminar T5 - Novel ways of dispensing drugs

Affiliation:
Apotheek A15 (A15 Pharmacy)
Country:
The Netherlands

 

Seminar T2 - Empowering patients through technology – "The Quantified Self"

Affiliation:
University Hospital Of Clermont-Ferrand
Country:
France

 

Seminar PH3 - Developing new strategies in bacterial infections

Affiliation:
Medical University of Vienna
Country:
Austria

 

Synergy Satellite: Interchangeability of biologicals in the EU – the science, practice, ethics and cost side? (supported by an educational grant from Roche)

Affiliation:
Erasmus University Medical Center Rotterdam
Country:
The Netherlands

 

Keynote 2 - Star Trek's tricorder: science fiction or future science?

Affiliation:
University of Geneva, Switzerland & University of Copenhagen, Denmark
Country:
Switzerland
Poster nominee oral presentations

Please find below the names of the 15 poster nominees.

The first poster nominee oral session will take place on Wednesday, 16 March from 14.00 to 15:30 in Hall 0.93.

  • MEDICINE SUPPLY CHAIN OF A CENTRAL PHARMACY : RISK MAPPING OF SHORTAGE - Charra, Florent;
  • CONTAMINATION WITH CYTOTOXIC DRUGS IN THE WORKPLACE - ESOP PILOT STUDY - Korczowska, Ewelina;
  • DOUBLE CHECKING MANIPULATIONS FOR COMPLEX AND/OR HIGH RISK PREPARATIONS - Alcobia Martins, Armando;
  • THE CLINICAL PHARMACIST RESOLVES MEDICATION RELATED PROBLEMS IN CRANIO, MAXILLOFACIAL AND ORAL SURGERY PATIENTS - Stemer, Gunar;
  • THE IMPACT OF PHARMACIST INTERVENTIONS ON SAFETY AND COST SAVINGS - Ibanez Garcia, Sara;
  • EFFECTIVENESS AND SAFETY OF SWITCHING TO DUAL ANTIRETROVIRAL THERAPY IN A TREATMENT EXPERIENCED HIV COHORT - Ruiz Martinez , Cristina;
  • IMPLEMENTATION AND EVALUATION OF AN APPOINTMENT BASED MODEL FOR OUTPATIENTS ATTENDED IN A HOSPITAL PHARMACY - Alvarez Mancenido, Felipe;
  • CLINICAL PHARMACOKINETICS OF EVEROLIMUS IN LUNG TRANSPLANTATION: STRATEGIES OF MONITORING - Martín Cerezuela, Maria.

The second poster nominee oral session will take place on Thursday, 17 March from 09.00 to 10:30 in Hall 0.93.

  • DOES THE COMPUTERIZED PHYSICIAN ORDER ENTRY SYSTEM REDUCE PRESCRIBING ERRORS FOR INPATIENTS ? A BEFORE-AFTER STUDY - Rouayroux, Naïs;
  • APPS FOR PAEDIATRIC DOSING - AN EVALUATION - Vonbach,Priska;
  • IMPROVING PHARMACOLOGICAL TREATMENT: REAL-TIME SAFETY AUDITS - López Broseta, Pilar Ana;
  • MATERIOVIGILANCE EX ANTE RISK MANAGEMENT - Dubromel, Amelie;
  • HEALTH-RELATED QUALITY OF LIFE AND ITS ASSOCIATED FACTORS AMONG SOUTH ASIAN AND MIDDLE EASTERN PATIENTS WITH CHRONIC DISEASES IN THE UK - Alhomoud, Faten;
  • INNAPPROPRIATE PRESCRIBING IN ELDERLY PATIENTS ATTENDING THE EMERGENCY ROOM - Gines, Ana;
  • PROSPECTIVE DETECTION OF ADVERSE DRUG REACTIONS AMONG 2,263 HOSPITALIZED CHILDREN OVER A 19-MONTH PERIOD - EREMI INTERMEDIATE REPORT - Lajoinie, Audrey.
Last update: 8 February 2016